Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Pneumonia & Flu

  • your selections
Clear Search

Filter Results

date

Tags

  • results
2-Day Meeting Examining Issues Of Censorship Of Scientific Studies Leaves Questions Unanswered

A two-day Royal Society meeting held this week in London — which examined “whether scientific journals should occasionally publish censored versions of papers because the full ones might prove useful to terrorists” — “brought scientists no closer to resolving the question of whether there are any kinds of experiments whose results should be kept from the public,” the Washington Post reports. “The audience of about 200 scientists and ethicists considered numerous questions,” the newspaper writes, noting, “There was general agreement that some experiments are off limits, such as attempting to make the AIDS virus transmissible by air,” but “[t]here was less agreement about the experiments at hand, which changed the characteristics of H5N1 bird flu.”

Funders Should Follow Lead Of U.S. In Creating Policies For Scientific Research Oversight

“[T]he controversy over the research into the genetic modification of the H5N1 flu virus, finally approved for publication, should offer a reminder of the importance of debate” over dual-use technology, a Nature editorial states. “[D]ual-use basic research is a special case because its implications, for good and bad, are often viewed with the greatest clarity by only a small minority of people,” and often only “[t]he scientists involved (and they are increasingly specialists in very small fields) … can fully understand the risks posed by a line of research,” according to the editorial. “There are disadvantages to leaving it up to outsiders to initiate debate about risks, benefits and ethics,” the editorials states, noting three disadvantages, including the risk of misconceptions and a lack of knowledge about how to handle some research.

Ghanaian Vaccination Campaign Hopes To Prevent Up To 14,000 Child Deaths

In a Huffington Post Blog opinion piece, Orin Levine, executive director of the International Vaccine Access Center (IVAC), describes watching the suffering of an infant with severe pneumonia and his parents while in Ghana on Thursday, writing that the experience was “a personal reminder as to why our work to prevent disease is so perilous, and why disease control so promising in Africa.” Noting that last year in Ghana, “approximately 50,000 young children — nearly seven out of every 100 — died before their fifth birthday,” Levine adds, “I also saw the promise of prevention in Ghana,” with the launch of an immunization campaign to provide both pneumococcal and rotavirus vaccines. With support from the GAVI Alliance, Ghana is the first country in Africa to introduce two new vaccines against pneumonia and diarrhea at the same time,” he notes.

U.S. Government Must Be Prepared To Handle Dual Use Research Of Concern

“This week, a Senate panel is investigating biological security in the wake of” controversial “potentially dangerous research” on H5N1 avian influenza, “with good reason,” Rep. Jim Sensenbrenner (R-Wisc.) writes in a Washington Times opinion piece. He says “the U.S. government should not have been caught by surprise” by the two research papers describing how genetic mutations to the virus could make it transmissible between ferrets, because the National Science Advisory Board for Biosecurity (NSABB) “was created in 2004 and charged with the specific responsibility of reviewing this type of research and offering guidance to all federal agencies that conduct biological research.” Sensenbrenner says the NSABB’s initial recommendation against publishing the studies and its subsequent reversal of that decision has left him with “suspicions that the U.S. government is woefully unprepared for dealing with dual use research of concern — research that, while conducted for a legitimate scientific purpose, could be dangerous if misused.”

Dutch Government Rule Export Permit Required To Publish Controversial Bird Flu Study

Ron Fouchier of Erasmus Medical Center, “[t]he Dutch scientist at the center of the controversy over recent bird flu experiments, says that his team applied for government permission today to submit a paper describing their research to a science journal,” NPR’s health blog “Shots” reports, adding, “The Dutch government has asserted that the studies, which describe how to make bird flu virus more contagious, fall under regulations that control the export of weapons technology.” According to the news service, “He feels the government’s actions amount to censorship and has previously has said he did not want to apply for an export permit, because it would set a precedent” (Greenfieldboyce, 4/24). “Fouchier says that by conceding to the government’s request while continuing to contest the need for an export permit, he hopes to have found an acceptable compromise,” Nature writes.

U.S. Gives Go-Ahead On Publication Of H5N1 Research; Dutch Regulators Continue To Debate

The U.S. government on Friday formally accepted a recommendation from the National Science Advisory Board for Biosecurity (NSABB) “to publish two controversial studies of the H5N1 avian influenza virus, moving the pair of papers another step closer to publication,” ScienceInsider reports (Malakoff, 4/20). “Groups led by the two scientists — Yoshihiro Kawaoka of the University of Wisconsin and Ron Fouchier of Erasmus Medical Center in Rotterdam — engineered the H5N1 virus to be more transmissible between ferrets, mammals whose response to the flu is most like humans,” Bloomberg Businessweek notes. “The research is critical to understanding and detecting bird flu strains, Health and Human Services Secretary Kathleen Sebelius and Francis Collins, director of the National Institutes of Health, said [on Friday] in a statement,” Bloomberg writes, noting that the NSABB “recommended in March that Sebelius and Collins approve publication” (Wayne, 4/20).

Large Childhood Immunization Campaign Begins In Haiti, With Support From U.S., Other International Partners

Haiti, the U.S. and other international partners on Monday launched “a nationwide vaccination campaign in the Caribbean country that seeks to curb or prevent infectious diseases, health officials said,” the Associated Press/Fox News reports. The campaign will include immunizations against measles, rubella and polio, as well as the pentavalent vaccine, which is effective against diphtheria, tetanus, whooping cough, hepatitis B and Haemophilus influenza type b, according to the news agency. Immunization rates are low in Haiti, with the WHO reporting slightly more than half of the population immunized for measles and polio, but the current campaign aims to vaccinate 90 percent of Haiti’s youth population, according to Health Minister Florence Duperval Guillaume, the news agency notes.

NSABB Recommends Full Publication Of Controversial Bird Flu Studies

The National Science Advisory Board for Biosecurity (NSABB) on Friday recommended that revised versions of two controversial studies on H5N1 avian flu be published in scientific journals, reversing its previous recommendation that the studies only be published if certain details were withheld, the New York Times reports. The studies are the work of two research teams that created genetically altered viral strains that were airborne and therefore easily transmissible, the newspaper notes (Grady, 3/30). “In a statement [.pdf] released [Friday], the NSABB said it unanimously recommended that the revised manuscript by the University of Wisconsin group, headed by Yoshihiro Kawaoka, DVM, PhD, be published in full, and members voted 12 to six that the data, methods, and conclusions in the revised paper by the Erasmus group, headed by Ron Fouchier, PhD, be published,” CIDRAP News writes (Schnirring, 3/30).

NSABB Calls For Global Guidelines For Conducting, Communicating Research Involving Dangerous Pathogens

NewScientist reports on the U.S. National Science Advisory Board for Biosecurity’s (NSABB) recommendation that revised versions of two controversial studies on H5N1 avian flu be published in scientific journals, reversing its previous recommendation that the studies only be published if certain details were withheld. According to the news service, dissent among the board members over the issue has prompted the committee to “propos[e] talks to draft global guidelines for doing and communicating work involving dangerous pathogens.”

Discussion Of NSABB Recommendation To Publish Controversial Bird Flu Studies To Continue In London Meeting

The National Science Advisory Board for Biosecurity’s (NSABB) “reversal on publishing two controversial H5N1 studies is poised to shift discussions on the topic that continue in London this week, as more participants in the debate weigh in following the March 30 announcement,” CIDRAP News reports (Schnirring, 4/2). But Paul Keim of Northern Arizona University, who is the acting chair of the panel, stressed on Monday that the “recommendation that two controversial papers on bird flu be published in full is not a reversal of the stand it took last year out of concerns over terrorism,” Reuters writes. “‘We had new information, confidential information, about benefits of this research, and we also had confidential information about the risks involved,'” Keim said, according to the news service (Kelland/Begley, 4/2).